Bryan Kay

3 POSTS 0 COMMENTS

TCAR yields “high technical success, with an extraordinarily low stroke and...

Outcomes in a cohort of patients who consented to one year of follow-up after transcarotid revascularisation (TCAR; Silk Road Medical) treatment for carotid stenosis...

Study detects no difference in adverse outcomes from balloon dilatation strategy...

Avoiding a strategy of post-stent balloon dilation during transcarotid artery revascularisation (TCAR) may be unnecessary—a “contradistinction” to results shown in conventional transfemoral carotid artery...

Study shows novel AI technology is better predictor of stroke than...

Boston-based medical technology company Elucid Bio, maker of the Food and Drug Administration (FDA)-cleared and CE-marked vascuCAP software, announced Wednesday, July 1, that its...